A detailed history of Round Angle Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Round Angle Advisors LLC holds 1,974 shares of LLY stock, worth $1.59 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares
1,974
Holding current value
$1.59 Million
% of portfolio
1.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$727.2 - $932.06 $1.44 Million - $1.84 Million
1,974 New
1,974 $1.52 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Round Angle Advisors LLC Portfolio

Follow Round Angle Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Angle Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Angle Advisors LLC with notifications on news.